Cell Dissociation Market by Product Type (Enzymatic Dissociation Products and Instruments), Tissue (Connective Tissues, Epithelial Tissues, and Others), Dissociation (Tissue Dissociation and Cell Detachment), and End User (Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, and Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030

Cell Dissociation Market Overview 2030:

The process of cell dissociation, also known as trypsinization, involves a proteolytic enzyme that aids in the breakdown of protein to dissociate adhered cells from the cell culture vessel. This breakdown is necessary so that the cells could be used further. Cell dissociation reagents can carry out proteolytic and collagenolytic activities to disengage the cell tissues and lines from glass and plastic surfaces of the container to increase cell viability and isolation efficiency. The selection of the cell dissociation agent depends on the tissue or cell type and on the age of the cells in the culture medium.

Market Scope and Structure Analysis

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the biotechnology industry is expected to witness significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.

COVID-19 is expected to have a significant impact on the cell dissociation market, as the supply chain of raw materials required to manufacture the products for cell dissociation has been disrupted in many countries. In addition, the market growth of cell dissociation enzymes is declining, as the manufacturers of these products have slowed down their production due to the pandemic.

Top Impacting Factors

The growth of the cell dissociation market is primarily by the prevalence of cell-based research initiated by many pharmaceutical and biotechnology companies.

In addition, the number of these pharmaceutical and biotechnological companies is increasing all over the world. Hence, this is another factor fueling the growth of the cell dissociation market.

The biotechnology industry needs advanced enzymes that help dissociate tissues. This demand is further leading to the growth of the market.

However, ethical restrictions and concerns on the use of cell-based research in many regions of the world are limiting the growth of cell biology.

Key Market Trends

The enzymatic cell dissociation products segment is expected to witness lucrative growth during the forecast period, owing to increase in incidence of research where these types of enzymes are often used.

The emerging markets such as Brazil, India, and China are expected to offer significant growth opportunities for key players in the market. The expected growth can be attributable to rise in the number of cell-based research and development activities in these regions.

Key players in the market are investing in toxicity studies and efficacy studies related to cell dissociation enzymes. This factor is further expected to lead to the immense growth of the cell dissociation market during the forecast period.

North America and Europe lead the cell dissociation market, due to favorable research and development investments in many biotechnology studies, which often require cell dissociation products during the process.

Key Segments Covered

Key Benefits of the Report

• This study presents the analytical depiction of the cell dissociation industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Cell Dissociation Report

• Which are the leading players active in the cell dissociation market?
• How is each segment of the market expected to grow during the forecast period?
• What are the adoption trends for the cell dissociation market in emerging economies and established economies across the world?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the market?
• What future projections would help in taking further strategic steps?
• What are the impacts of COVID-19 in the industry?
• What is cell dissociation?
• What are the current trends and predicted trends?

 Key Market Segments

 
Key Market Players

• VitaCyte, LLC
• Thermo Fisher Scientific Inc.
• PAN-Biotech
• Merck KGaA
• HiMedia Laboratories
• Miltenyi Biotec GmbH
• STEMCELL Technologies Inc.
• General Electric Company
• Roche Diagnostics
• Becton, Dickinson and Company